Bradmer Pharmaceuticals Inc. (TSE:GLX) Given Consensus Recommendation of “Buy” by Brokerages

Bradmer Pharmaceuticals Inc. (TSE:GLX) has received a consensus rating of “Buy” from the six analysts that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, one has given a buy rating and three have assigned a strong buy rating to the company.

GLX has been the subject of several research reports. Citigroup raised shares of Bradmer Pharmaceuticals to a “hold” rating in a research report on Tuesday, February 24th. ATB Cormark Capital Markets downgraded shares of Bradmer Pharmaceuticals from a “strong-buy” rating to a “moderate buy” rating in a research report on Thursday, February 5th.

Bradmer Pharmaceuticals Price Performance